Prezista Tablet, Film Coated
Product Images NDC 59676-562

18 FDA label images from Janssen Products Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Prezista (NDC 59676-562). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Products Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Prezista 01)

Chemical Structure (Prezista 01)
Chemical structure of darunavir, the active ingredient in PREZISTA tablets. The structure includes multiple rings, functional groups such as hydroxyl, amide, and sulfonamide, and a labeled ethanol molecule (C2H5OH).*
FDA Label Image

Figure 1 (Prezista 02)

Figure 1 (Prezista 02)
Two forest plot charts depicting geometric mean ratios (GMR) with 90% confidence intervals for PREZISTA (darunavir) pharmacokinetic parameters during the second and third trimesters of pregnancy. Parameters shown include total and unbound AUC and Cmin for twice daily and once daily dosing regimens, illustrating comparisons of drug exposure across trimesters.*
FDA Label Image

Figure (Prezista 03)

Figure (Prezista 03)
An instructional diagram showing a bottle, a syringe with labeled barrel and plunger, and an adapter piece. This illustration likely demonstrates the components used for measuring and administering liquid medication from a bottle using a syringe and adapter.*
FDA Label Image

Figure A (Prezista 04)

Figure A (Prezista 04)
An instructional illustration showing a hand holding a bottle upright, with arrows indicating to shake the bottle up and down. This diagram suggests the proper method to shake the product before use.*
FDA Label Image

Figure B (Prezista 05)

Figure B (Prezista 05)
An instructional illustration showing how to open a child-resistant bottle cap. The first panel demonstrates twisting the cap counterclockwise, and the second panel shows lifting the cap off the bottle after twisting.*
FDA Label Image

Figure C (Prezista 06)

Figure C (Prezista 06)
An instructional illustration showing the steps to open and prepare a bottle for use. The first image depicts a hand unscrewing the cap from a bottle, the second image shows hands holding the bottle near a cup filled with liquid, and the third image shows the bottle without a cap, partially filled with liquid inside.*
FDA Label Image

Figure D (Prezista 07)

Figure D (Prezista 07)
An instructional illustration showing a hand holding a bottle while another hand uses a syringe to withdraw liquid from the bottle, indicated by a downward arrow suggesting the syringe insertion direction.*
FDA Label Image

Figure E (Prezista 08)

Figure E (Prezista 08)
An instructional line drawing showing a person holding a bottle upside down and drawing liquid into a syringe from the bottle. The image depicts a step in medication preparation for oral administration.*
FDA Label Image

Figure F (Prezista 09)

Figure F (Prezista 09)
Illustration showing a person withdrawing liquid from a bottle using a syringe. The left panel depicts the syringe inserted into the bottle, while the right panel shows the syringe being pulled upward to draw the liquid out. The images demonstrate proper technique for using a syringe to extract medication from a vial or bottle.*
FDA Label Image

Figure G (Prezista 10)

Figure G (Prezista 10)
Illustration showing a person administering an oral medication using an oral syringe. The syringe is held near the mouth, demonstrating the dosing method by mouth.*
FDA Label Image

Figure H (Prezista 11)

Figure H (Prezista 11)
An instructional illustration showing a hand turning the child-resistant cap of a bottle counterclockwise to open it. The image demonstrates the proper way to open a safety cap by gripping and twisting.*
FDA Label Image

Figure I (Prezista 12)

Figure I (Prezista 12)
An instructional illustration showing two hands pulling apart a syringe and its protective cap, with double-headed arrows indicating separation. This likely demonstrates how to remove the syringe cap before use.*
FDA Label Image

Figure J (Prezista 12a)

Figure J (Prezista 12a)
An instructional illustration showing one hand holding a syringe while a second hand pulls back the plunger, indicated by a bold arrow pointing upward. This image demonstrates proper syringe preparation technique.*
FDA Label Image

Prezista 75 mg Pdp (Prezista Tablet 75 mg 018)

Prezista 75 mg Pdp (Prezista Tablet 75 mg 018)
Label for PREZISTA (darunavir) tablets, 75 mg strength, film-coated oral tablets. The label includes a warning to find out about medicines that should not be taken with PREZISTA. It is manufactured for Janssen Products, LP by Johnson & Johnson and contains 480 tablets. The label also features storage instructions and recommended dosage notes.*
FDA Label Image

Prezista 150 mg Pdp (Prezista Tablets 150 mg 019)

Prezista 150 mg Pdp (Prezista Tablets 150 mg 019)
Label for PREZISTA (darunavir) tablets, 150 mg strength, film-coated oral tablets. The label indicates a package of 240 tablets, manufactured for Janssen Products LP by Johnson & Johnson. It includes a warning alert about medicines that should not be taken with PREZISTA. The NDC is 59676-564-01.*
FDA Label Image

Prezista 600 mg Pdp (Prezista Tablets 600 mg 20)

Prezista 600 mg Pdp (Prezista Tablets 600 mg 20)
PREZISTA 600 mg (darunavir) film-coated tablets label. The label shows the strength as 600 mg, the product is oral tablets by Janssen Products LP, with package count of 60 tablets. Manufacturer mention is Johnson & Johnson. The label includes storage instructions and dosage recommendations.*
FDA Label Image

Prezista 800 mg Pdp (Prezista Tablets 800 mg 021)

Prezista 800 mg Pdp (Prezista Tablets 800 mg 021)
PREZISTA (darunavir) tablets 800 mg film-coated oral tablets carton label. The package contains 30 tablets and is labeled by Janssen Products LP, part of Johnson & Johnson. The label includes NDC 59676-566-30 and storage instructions, highlighting an alert about medicines that should not be taken with PREZISTA.*
FDA Label Image

Prezista Os Pdp (Prezista Os 100 mg Per mL 200 mL 022)

Prezista Os Pdp (Prezista Os 100 mg Per mL 200 mL 022)
Packaging label for PREZISTA (darunavir) Oral Suspension, 100 mg per mL. The label includes dosage information, storage instructions, and a warning alert about medicines that should not be taken with PREZISTA. The product is manufactured by Janssen Products LP and distributed by Johnson & Johnson. The package size indicated is 200 mL, and the label features a barcode and NDC 59676-565-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.